Back
Unmet Needs in the Treatment of Rheumatoid Arthritis
Janet Pope, Bernard Combe
Open J. Rheumatol. Autoimmune Dis. Vol.3 No.2, May 16, 2013  DOI: 10.4236/ojra.2013.32011
       (PDF  352K)     HTML     
Sphaeranthus indicus: Traditional Wisdom to Modern Medicine—An Orally Active, Potent Cytokine Inhibitor for the Management of Inflammatory Disorders
Jacqueline Trivedi, Firuza Kharas, Sapna Parikh, Roda Dalal, Aurelio Lobo, Lyle Fonseca, Mahesh Jadhav, Shruta Dadarkar, Asha Almeida, Ankita Srivastava, Ashish Suthar
Pharmacol. Pharm. Vol.7 No.2, February 24, 2016  DOI: 10.4236/pp.2016.72014
       (PDF  1103K)     HTML      XML
Perioperative Use of Methotrexate and Tumor Necrosis Factor α Inhibitors Combination Therapy Is Not Likely to Increase Post-Operative Infection Rate in the National Veterans Health Administration Administrative Databases
Hsin-Hsuan Juo, Anders Peck, Sarah E. Monsell, Bernard Ng
Open J. Rheumatol. Autoimmune Dis. Vol.9 No.1, February 03, 2019  DOI: 10.4236/ojra.2019.91001
       (PDF  469K)     HTML      XML
Antibodies to Tumor Necrosis Factors in the Treatment of Rheumatoid Arthritis and Spondyloarthritis: The Basic Science, Clinical Science and Unmet Needs; Results from a Single Center
Sundeep Kumar Upadhyaya
Open J. Rheumatol. Autoimmune Dis. Vol.4 No.2, May 04, 2014  DOI: 10.4236/ojra.2014.42013
       (PDF  261K)     HTML      XML
Effect of Anti-TNF Therapy on Resistance to Insulin in Patients with Rheumatoid Arthritis
Mario Pérez, Raul Ariza, Ruben Asencio, Adolfo Camargo, Heladia Garcia, Miguel Angel Vazquez, Leonor Barile-Fabris
Open J. Rheumatol. Autoimmune Dis. Vol.3 No.3, August 16, 2013  DOI: 10.4236/ojra.2013.33026
       (PDF  147K)     HTML     
 
 
Top